Our laboratories are outfitted with some of the latest technological tools, such as a 3D bioprinter that could one day print artificial organs. In our clean room facility, healthy islet cells are taken from a patient’s inflamed pancreas, then given back to the patient, reducing inflammation and pain while conserving the patient’s ability to naturally control blood sugar.
Dr. Agarwal is a transplant surgeon and is also involved in clinical trials and research. He is a principal investigator for the Cellular Therapy & Transplant Core. Dr. Agarwal’s goals include developing new approaches to help patients adhere to the post-transplant immunosuppressive regimen of medications, which is necessary to ensure their body has the best chance of accepting the graft and returning to health.